The World Conference on Interventional Oncology (WCIO) will promote dialogue on available and emerging minimally invasive oncologic therapies at the Sheraton Chicago Hotel and Towers, Chicago, USA from 14–17 June 2012.
“WCIO 2012 provides a forum for cross-disciplinary collaboration and education, and is designed for physicians and care-givers from all medical fields involved in the care of the cancer patient,” said Riad Salem, WCIO 2012 program chair, and professor of Radiology, Medicine and Surgery, director of Interventional Oncology at Northwestern University, Chicago, Illinois, USA.
WCIO 2012 leverages a combination of a world-class faculty with state-of-the-art lectures, panel discussions, invited papers, and selected abstracts of basic, translational, and clinical research to promote meaningful dialogue on available and emerging therapies in Radiology, Medical Oncology, Surgical Oncology, Interventional Oncology, Hepatology, Basic Science Research, and Radiation Oncology.
Key presentations include:
- Randomised evidence on the use of drug-eluting microspheres in colorectal cancer
- Long-term outcomes of thermal ablation for metastatic tumors in the lung
- Improvements in long-term survival of hepatocellular carcinoma
- Comparative effectiveness of open and percutaneous ablation in RCC
- Automated segmentation of tumors
- Early outcomes of irreversible electroporation
- Radioembolization in cholangiocarcinoma, neuroendocrine and other neoplasia
- Transarterial immunotherapy in HCC
- Nanotechnology
- Drug-eluting outcomes with new 70-150 micron particles
This year WCIO will feature live cases on tumour ablation and embolization. It will also present a symposium on “Interventional Techniques: Top 10 clinical pearls” and an “Interventional radiology fellow’s symposium”.
